Tetratherix Ltd
Company Profile
Business description
Tetratherix Ltd is a platform technology and multiple products with a wide range of healthcare applications are under development by using its proposition and characteristics. It integrates and adheres to target tissues to support biological processes or simplify surgical interventions. The company has a well-progressed product portfolio that leverages the core Tetramatrix platform technology. This includes applications for bone regeneration, tissue spacing in oncological and ophthalmic settings and tissue healing to reduce scarring. The company's primary source of income originates from the ongoing manufacture and supply of products developed with the Tetramatrix platform technology.
Contact
Unit 29, 34-36 Ralph Street
Alexandria
SydneyNSW2015
AUST: +61 425366073
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
Employees
Stocks News & Analysis
stocks
4 ASX shares that could be vulnerable to an August surprise
stocks
Another incredible quarter from Microsoft
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,917.10 | 81.90 | -0.91% |
| CAC 40 | 7,546.16 | 225.81 | -2.91% |
| DAX 40 | 23,425.97 | 639.50 | -2.66% |
| Dow JONES (US) | 43,588.58 | 542.40 | -1.23% |
| FTSE 100 | 9,068.58 | 64.23 | -0.70% |
| HKSE | 24,507.81 | 265.52 | -1.07% |
| NASDAQ | 20,650.13 | 472.31 | -2.24% |
| Nikkei 225 | 40,799.60 | 270.22 | -0.66% |
| NZX 50 Index | 12,729.40 | 94.34 | -0.74% |
| S&P 500 | 6,238.01 | 101.38 | -1.60% |
| S&P/ASX 200 | 8,662.00 | 80.80 | -0.92% |
| SSE Composite Index | 3,559.95 | 13.26 | -0.37% |